Broadcast Drug Ads Down In 2005 While Overall Consumer Promotions Rise
The number of broadcast direct-to-consumer ads disseminated by the pharmaceutical industry dropped by 24% in 2005, according to FDA
More from Archive
More from Pink Sheet
• By
If approved, Sanofi’s acoziborole could become the first single-dose oral treatment for sleeping sickness.
• By
Mexico’s drugs regulator will be able to grant quicker drug approvals based on decisions issued by World Health Organization listed authorities and founding ICH members.
• By
Biogen has U-turned on its original decision not to file Qalsody for marketing approval in the UK for treating certain patients with amyotrophic lateral sclerosis. The move appears to have been triggered by a change in the reimbursement pathway agreed for the product.